Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,828.80
(
-0.48%
)
Dow Jones
49,447.43
(
1.88%
)
Brent Oil
91.56
(
-1.19%
)
Bitcoin
75,168.31
(
1.77%
)
News Focus
News Focus
Post# of 257426
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: oc631 post# 126127

Monday, 09/05/2011 2:17:27 PM

Monday, September 05, 2011 2:17:27 PM

Post# of 257426
There's an ongoing (three drug) phase 2 study of GS9190 plus PegRiba which appears to remain active.



http://clinicaltrials.gov/ct2/show/NCT00743795?term=GS9190&rank=2
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today